Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: The Orcharrd Study (OMB110928) Meeting Abstract
| Authors: | van Imhoff, G. W.; McMillan, A.; Matasar, M. J.; Radford, J.; Ardeshna, K. M.; Kuliczkowski, K.; Kim, W.; Hong, X. N.; Goerloev, J. S.; Davies, A.; Barrigon, M. D. C.; Ogura, M.; Fennessy, M.; Liao, Q. M.; van der Holt, B.; Lisby, S.; Lin, T. S.; Hagenbeek, A. |
| Abstract Title: | Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: The Orcharrd Study (OMB110928) |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349233806204 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.630.630 |
| Notes: | Meeting Abstract: 630 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
